-
2
-
-
0021093668
-
Liver transplants: Big business in blood
-
Goldsmith MF. Liver transplants: big business in blood. JAMA. 1983;250:2904-2905.
-
(1983)
JAMA
, vol.250
, pp. 2904-2905
-
-
Goldsmith, M.F.1
-
4
-
-
0023213896
-
Hepatic transplantation in Europe
-
First report of the European Liver Transplant Registry
-
Bismuth H, Castaing D, Ericzon BG, et al. Hepatic transplantation in Europe. First report of the European Liver Transplant Registry. Lancet. 1987;2:674-676.
-
(1987)
Lancet
, vol.2
, pp. 674-676
-
-
Bismuth, H.1
Castaing, D.2
Ericzon, B.G.3
-
6
-
-
0027244838
-
Factors influencing blood transfusion during liver transplantation
-
Deakin M, Gunson BK, Dunn JA, et al. Factors influencing blood transfusion during liver transplantation. Ann R Coll Surg Engl. 1993;75:339-344.
-
(1993)
Ann R Coll Surg Engl
, vol.75
, pp. 339-344
-
-
Deakin, M.1
Gunson, B.K.2
Dunn, J.A.3
-
7
-
-
0031265843
-
Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantation
-
Kang Y. Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantation. Liver Transpl Surg. 1997;3:655-659.
-
(1997)
Liver Transpl Surg
, vol.3
, pp. 655-659
-
-
Kang, Y.1
-
8
-
-
0030694353
-
A surgeon's perspective on the management of coagulation disorders before liver transplantation
-
Bechstein WO, Neuhaus P. A surgeon's perspective on the management of coagulation disorders before liver transplantation. Liver Transpl Surg. 1997;3:653-655.
-
(1997)
Liver Transpl Surg
, vol.3
, pp. 653-655
-
-
Bechstein, W.O.1
Neuhaus, P.2
-
9
-
-
0027392836
-
The impact of operative bleeding on outcome in transplantation of the liver
-
Mor E, Jennings L, Gonwa TA, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet. 1993;176:219-227.
-
(1993)
Surg Gynecol Obstet
, vol.176
, pp. 219-227
-
-
Mor, E.1
Jennings, L.2
Gonwa, T.A.3
-
10
-
-
0346958515
-
Intraoperative red blood cell transfusion in liver transplantation: Influence on patient outcome, prediction of requirements, and measures to reduce them
-
Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transplant. 2003;9:1320-1327.
-
(2003)
Liver Transplant
, vol.9
, pp. 1320-1327
-
-
Ramos, E.1
Dalmau, A.2
Sabate, A.3
-
11
-
-
0034089527
-
Blood loss in orthotopic liver transplantation: A retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients
-
Hendriks HGD, van der Meer J, Klompmaker IJ, et al. Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coag Fibrinol. 2000;11:S87-S93.
-
(2000)
Blood Coag Fibrinol
, vol.11
-
-
Hendriks, H.G.D.1
Van Der Meer, J.2
Klompmaker, I.J.3
-
12
-
-
0032932032
-
Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation
-
Cacciarelli TV, Keeffe EB, Moore DH, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg. 1999;134:25-29.
-
(1999)
Arch Surg
, vol.134
, pp. 25-29
-
-
Cacciarelli, T.V.1
Keeffe, E.B.2
Moore, D.H.3
-
13
-
-
0027162130
-
Coagulation and fibrinolysis in orthotopic liver transplantation: Current views and insights
-
Porte RJ. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights. Semin Thromb Hemost. 1993;19:191-196.
-
(1993)
Semin Thromb Hemost
, vol.19
, pp. 191-196
-
-
Porte, R.J.1
-
14
-
-
12344266674
-
Hematologic considerations in the transplant patient
-
Sharpe MD, Gelb AW, eds. Boston: Butterworth Heinemann
-
Kang Y, Gaisor TA. Hematologic considerations in the transplant patient. In: Sharpe MD, Gelb AW, eds. Anesthesia and Transplantation. Boston: Butterworth Heinemann; 1999:363-387.
-
(1999)
Anesthesia and Transplantation
, pp. 363-387
-
-
Kang, Y.1
Gaisor, T.A.2
-
15
-
-
0021815571
-
Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation
-
Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg. 1985;64:888-896.
-
(1985)
Anesth Analg
, vol.64
, pp. 888-896
-
-
Kang, Y.G.1
Martin, D.J.2
Marquez, J.3
-
17
-
-
0003338015
-
Intraoperative coagulation changes in liver transplantation
-
Winter PM, Kang YG, eds. New York: Praeger
-
Lewis JH, Bontempo FA, Kang YG, et al. Intraoperative coagulation changes in liver transplantation. In: Winter PM, Kang YG, eds. Hepatic Transplantation. New York: Praeger; 1986:142-150.
-
(1986)
Hepatic Transplantation
, pp. 142-150
-
-
Lewis, J.H.1
Bontempo, F.A.2
Kang, Y.G.3
-
18
-
-
0024413449
-
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation
-
Porte RJ, Bontempo FA, Knot EA, et al. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation. 1989;47:978-984.
-
(1989)
Transplantation
, vol.47
, pp. 978-984
-
-
Porte, R.J.1
Bontempo, F.A.2
Knot, E.A.3
-
19
-
-
0026721012
-
Increased tissue-type plasminogen actvator activity in orthotopic but not in heterotopic liver transplantation. The role of the anhepatic period
-
Bakker CM, Metselaar HJ, Groenland THN, et al. Increased tissue-type plasminogen actvator activity in orthotopic but not in heterotopic liver transplantation. The role of the anhepatic period. Hepatology. 1992;16:40-48.
-
(1992)
Hepatology
, vol.16
, pp. 40-48
-
-
Bakker, C.M.1
Metselaar, H.J.2
Groenland, T.H.N.3
-
21
-
-
0023252175
-
Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation
-
Kang YG, Lewis JH, Navalgund A, et al. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology. 1987;66:766-773.
-
(1987)
Anesthesiology
, vol.66
, pp. 766-773
-
-
Kang, Y.G.1
Lewis, J.H.2
Navalgund, A.3
-
22
-
-
0027210811
-
Coagulation and liver transplantation
-
Kang Y. Coagulation and liver transplantation. Transplant Proc. 1993;25:2001-2005.
-
(1993)
Transplant Proc
, vol.25
, pp. 2001-2005
-
-
Kang, Y.1
-
23
-
-
0027162129
-
Hemostasis in advanced liver disease
-
Paramo JA, Rocha E. Hemostasis in advanced liver disease. Semin Thromb Hemost. 1993;3:184-190.
-
(1993)
Semin Thromb Hemost
, vol.3
, pp. 184-190
-
-
Paramo, J.A.1
Rocha, E.2
-
24
-
-
0029866673
-
Disseminated intravascular coagulation: Diagnosis and treatment
-
Baglin T. Disseminated intravascular coagulation: diagnosis and treatment. BMJ. 1996;312:683-686.
-
(1996)
BMJ
, vol.312
, pp. 683-686
-
-
Baglin, T.1
-
26
-
-
0027502957
-
Fibrinopeptide A in liver cirrhosis: Evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease
-
Mombelli G, Fiori G, Monotto R, et al. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease. J Lab Clin Med. 1993;121:83-90.
-
(1993)
J Lab Clin Med
, vol.121
, pp. 83-90
-
-
Mombelli, G.1
Fiori, G.2
Monotto, R.3
-
27
-
-
0024524802
-
Liver transplantation: Intraoperative changes in coagulation factors in 100 first transplants
-
Lewis JH, Bontempo FA, Kang YG, et al. Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology. 1989;9:710-714.
-
(1989)
Hepatology
, vol.9
, pp. 710-714
-
-
Lewis, J.H.1
Bontempo, F.A.2
Kang, Y.G.3
-
28
-
-
20244371478
-
Prothrombin fragment 1+2 and thrombin-antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation
-
Monteagudo J, Reverter JC, Pereira A, et al. Prothrombin fragment 1+2 and thrombin-antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation. Haemostasis. 1993;23:51-57.
-
(1993)
Haemostasis
, vol.23
, pp. 51-57
-
-
Monteagudo, J.1
Reverter, J.C.2
Pereira, A.3
-
29
-
-
0017652037
-
The coagulation disorder of orthotopic hepatic transplantation
-
Böhmig HJ. The coagulation disorder of orthotopic hepatic transplantation. Semin Thromb Hemost. 1977;4:57-82.
-
(1977)
Semin Thromb Hemost
, vol.4
, pp. 57-82
-
-
Böhmig, H.J.1
-
30
-
-
0023902721
-
Control of hemostasis during orthotopic liver transplantation
-
Palareti G, de Rosa V, Fortunato G, et al. Control of hemostasis during orthotopic liver transplantation. Fibrinolysis. 1988;2(Suppl 3):61-66.
-
(1988)
Fibrinolysis
, vol.2
, Issue.SUPPL. 3
, pp. 61-66
-
-
Palareti, G.1
De Rosa, V.2
Fortunato, G.3
-
31
-
-
0024455395
-
Coagulation changes following hepatic revascularization during liver transplantation
-
Harper PL, Luddington RJ, Jennings I, et al. Coagulation changes following hepatic revascularization during liver transplantation. Transplantation. 1989;48:603-607.
-
(1989)
Transplantation
, vol.48
, pp. 603-607
-
-
Harper, P.L.1
Luddington, R.J.2
Jennings, I.3
-
32
-
-
0030725326
-
The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease
-
Scherer R, Kabatnik M, Erhard J, et al. The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease. Intensive Care Med. 1997;23:1150-1158.
-
(1997)
Intensive Care Med
, vol.23
, pp. 1150-1158
-
-
Scherer, R.1
Kabatnik, M.2
Erhard, J.3
-
33
-
-
0026490262
-
Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: A randomized trial
-
Baudo F, DeGasperi A, deCataldo F, et al. Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial. Thromb Res. 1992;68:409-416.
-
(1992)
Thromb Res
, vol.68
, pp. 409-416
-
-
Baudo, F.1
DeGasperi, A.2
DeCataldo, F.3
-
34
-
-
0025730880
-
Coagulation and fibrinolysis in liver transplantation. The role of the recipient's disease and the use of antithrombin-III concentrates
-
Palareti G, Legagni C, Maccaferri M, et al. Coagulation and fibrinolysis in liver transplantation. The role of the recipient's disease and the use of antithrombin-III concentrates. Haemostasis. 1991;21:68-76.
-
(1991)
Haemostasis
, vol.21
, pp. 68-76
-
-
Palareti, G.1
Legagni, C.2
Maccaferri, M.3
-
35
-
-
0036034918
-
Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery
-
Porte RJ, Leebeek FW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs. 2002;62:2193-2211.
-
(2002)
Drugs
, vol.62
, pp. 2193-2211
-
-
Porte, R.J.1
Leebeek, F.W.2
-
36
-
-
12344279132
-
Antifibrinolytics in orthotopic liver transplantation: Current status and controversies
-
Xia VW, Steadman RH. Antifibrinolytics in orthotopic liver transplantation: current status and controversies. Liver Transplant. 2005;11:10-18.
-
(2005)
Liver Transplant
, vol.11
, pp. 10-18
-
-
Xia, V.W.1
Steadman, R.H.2
-
37
-
-
0033005358
-
Tranexamic acid: A review of its use in surgery and other indications
-
Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005-1032.
-
(1999)
Drugs
, vol.57
, pp. 1005-1032
-
-
Dunn, C.J.1
Goa, K.L.2
-
38
-
-
0029861942
-
Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation
-
Boylan JF, Klinck JR, Sandler AN, et al. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology. 1996;85:1043-1048.
-
(1996)
Anesthesiology
, vol.85
, pp. 1043-1048
-
-
Boylan, J.F.1
Klinck, J.R.2
Sandler, A.N.3
-
39
-
-
0030799952
-
Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation
-
Kaspar M, Ramsay MA, Nguyen AT, et al. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg. 1997;85:281-285.
-
(1997)
Anesth Analg
, vol.85
, pp. 281-285
-
-
Kaspar, M.1
Ramsay, M.A.2
Nguyen, A.T.3
-
40
-
-
0033917175
-
Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation
-
Dalmau A, Sabate A, Acosta F, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg. 2000;91:29-34.
-
(2000)
Anesth Analg
, vol.91
, pp. 29-34
-
-
Dalmau, A.1
Sabate, A.2
Acosta, F.3
-
41
-
-
1242306991
-
The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: A comparative study
-
Dalmau A, Sabate A, Koo M, et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transplant. 2004;10:279-284.
-
(2004)
Liver Transplant
, vol.10
, pp. 279-284
-
-
Dalmau, A.1
Sabate, A.2
Koo, M.3
-
42
-
-
0033009619
-
Aprotinin. An update of its pharmacology and therapeutic use in open heart surgery and coronary artery by-pass surgery
-
Peters DC, Noble S. Aprotinin. An update of its pharmacology and therapeutic use in open heart surgery and coronary artery by-pass surgery. Drugs. 1999;57:233-260.
-
(1999)
Drugs
, vol.57
, pp. 233-260
-
-
Peters, D.C.1
Noble, S.2
-
43
-
-
0034655629
-
Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicenter randomised double-blind study
-
Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicenter randomised double-blind study. Lancet. 2000;355:1303-1309.
-
(2000)
Lancet
, vol.355
, pp. 1303-1309
-
-
Porte, R.J.1
Molenaar, I.Q.2
Begliomini, B.3
-
44
-
-
0034849429
-
Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomised, double-blind study
-
Findlay JY, Rettke SR, Ereth MH, et al. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomised, double-blind study. Liver Transplant. 2001;7:802-807.
-
(2001)
Liver Transplant
, vol.7
, pp. 802-807
-
-
Findlay, J.Y.1
Rettke, S.R.2
Ereth, M.H.3
-
45
-
-
0034926015
-
Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation
-
[letter]
-
Dalmau A, Sabate A, Koo M, et al. Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation [letter]. Anesth Analg. 2001;93:516.
-
(2001)
Anesth Analg
, vol.93
, pp. 516
-
-
Dalmau, A.1
Sabate, A.2
Koo, M.3
-
46
-
-
0013866782
-
Changes in blood coagulation, before and after hepatectomy or transplantation in dogs and man
-
von Kaulla KN, Kaye H, von Kaulla E, et al. Changes in blood coagulation, before and after hepatectomy or transplantation in dogs and man. Arch Surg. 1966;92:71-79.
-
(1966)
Arch Surg
, vol.92
, pp. 71-79
-
-
Von Kaulla, K.N.1
Kaye, H.2
Von Kaulla, E.3
-
47
-
-
0023252175
-
Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation
-
Kang Y, Lewis JH, Navalgund A, et al. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology. 1987;66:766-773.
-
(1987)
Anesthesiology
, vol.66
, pp. 766-773
-
-
Kang, Y.1
Lewis, J.H.2
Navalgund, A.3
-
48
-
-
0025737618
-
Does prophylactic epsilon-aminocaproic acid improve blood loss and coagulation in liver transplantation?
-
McSorley MW, Taraporewalla KJ. Does prophylactic epsilon-aminocaproic acid improve blood loss and coagulation in liver transplantation? Transplant Proc. 1991;23:1941.
-
(1991)
Transplant Proc
, vol.23
, pp. 1941
-
-
McSorley, M.W.1
Taraporewalla, K.J.2
-
49
-
-
0028927298
-
Aprotinin reduces the need for blood products during liver transplantation
-
Scudamore CH, Randall TE, Jewesson PJ, et al. Aprotinin reduces the need for blood products during liver transplantation. Am J Surg. 1995;169:546-549.
-
(1995)
Am J Surg
, vol.169
, pp. 546-549
-
-
Scudamore, C.H.1
Randall, T.E.2
Jewesson, P.J.3
-
50
-
-
0027210811
-
Coagulation and liver transplantation
-
Kang Y. Coagulation and liver transplantation. Transplant Proc. 1993;25:2001-2005.
-
(1993)
Transplant Proc
, vol.25
, pp. 2001-2005
-
-
Kang, Y.1
-
51
-
-
0021954364
-
Clinical application of inhibitors of fibrinolysis
-
Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;29:236-261.
-
(1985)
Drugs
, vol.29
, pp. 236-261
-
-
Verstraete, M.1
-
52
-
-
0026510317
-
High-dose aprotinin therapy: A review of the first five years' experience
-
Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth. 1992;6:76-100.
-
(1992)
J Cardiothorac Vasc Anesth
, vol.6
, pp. 76-100
-
-
Royston, D.1
-
53
-
-
0020678186
-
Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs
-
Fritz H, Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung. 1983;33:479-494.
-
(1983)
Arzneimittelforschung
, vol.33
, pp. 479-494
-
-
Fritz, H.1
Wunderer, G.2
-
54
-
-
0020986217
-
High-dose aprotinin (Trasylol) therapy - Is it save for the kidney?
-
Fischer JH, Knupfer P. High-dose aprotinin (Trasylol) therapy - is it save for the kidney? Langenbecks Arch Chir. 1983;360:241-249.
-
(1983)
Langenbecks Arch Chir
, vol.360
, pp. 241-249
-
-
Fischer, J.H.1
Knupfer, P.2
-
55
-
-
0027419287
-
Observations on the early renal uptake and later tubular metabolism of radiolabelled aprotinin (Trasylol) in man: Theoretical and practical considerations
-
Rustom R, Grime JS, Maltby P, et al. Observations on the early renal uptake and later tubular metabolism of radiolabelled aprotinin (Trasylol) in man: theoretical and practical considerations. Clin Sci (Colch). 1993;84:231-235.
-
(1993)
Clin Sci (Colch)
, vol.84
, pp. 231-235
-
-
Rustom, R.1
Grime, J.S.2
Maltby, P.3
-
56
-
-
0024509887
-
Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Trasylol)
-
Bidstrup BP, Royston D, Sapsford RN, et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989;97:364-372.
-
(1989)
J Thorac Cardiovasc Surg
, vol.97
, pp. 364-372
-
-
Bidstrup, B.P.1
Royston, D.2
Sapsford, R.N.3
-
57
-
-
0033524140
-
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
-
Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet. 1999;354:1940-1947.
-
(1999)
Lancet
, vol.354
, pp. 1940-1947
-
-
Levi, M.1
Cromheecke, M.E.2
De Jonge, E.3
-
58
-
-
0024347315
-
Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation
-
Neuhaus P, Bechstein WO, Lefebre B, et al. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet. 1989;2:924-925.
-
(1989)
Lancet
, vol.2
, pp. 924-925
-
-
Neuhaus, P.1
Bechstein, W.O.2
Lefebre, B.3
-
59
-
-
0027325754
-
Does aprotinin really reduce blood loss in orthotopic liver transplantation?
-
Groh J, Welte M, Azad SC, et al. Does aprotinin really reduce blood loss in orthotopic liver transplantation? Semin Thromb Hemost. 1993;19:306-308.
-
(1993)
Semin Thromb Hemost
, vol.19
, pp. 306-308
-
-
Groh, J.1
Welte, M.2
Azad, S.C.3
-
60
-
-
0028884192
-
Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation
-
Milroy SJ, Cottam S, Tan K, et al. Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation. Br J Anaesth. 1995;75:747-751.
-
(1995)
Br J Anaesth
, vol.75
, pp. 747-751
-
-
Milroy, S.J.1
Cottam, S.2
Tan, K.3
-
61
-
-
0029995641
-
Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation
-
Marcel RJ, Stegall WC, Suit T, et al. Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anesth Analg. 1996;82:1122-1125.
-
(1996)
Anesth Analg
, vol.82
, pp. 1122-1125
-
-
Marcel, R.J.1
Stegall, W.C.2
Suit, T.3
-
62
-
-
0030670450
-
The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study
-
Garcia-Huete L, Domenech P, Sabate A, et al. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology. 1997;26:1143-1148.
-
(1997)
Hepatology
, vol.26
, pp. 1143-1148
-
-
Garcia-Huete, L.1
Domenech, P.2
Sabate, A.3
-
63
-
-
0001151417
-
Aprotinin during liver transplantation
-
[letter]
-
Cottam S, Milroy SJ. Aprotinin during liver transplantation [letter]. Br J Anaesth. 1995;76:882.
-
(1995)
Br J Anaesth
, vol.76
, pp. 882
-
-
Cottam, S.1
Milroy, S.J.2
-
64
-
-
0035091880
-
Reduced need for vasopressors in patients receiving aprotinin during orthotopic liver transplantation
-
Molenaar IQ, Begliomini B, Martinelli G, et al. Reduced need for vasopressors in patients receiving aprotinin during orthotopic liver transplantation. Anesthesiology. 2001;94:433-439.
-
(2001)
Anesthesiology
, vol.94
, pp. 433-439
-
-
Molenaar, I.Q.1
Begliomini, B.2
Martinelli, G.3
-
65
-
-
0037300068
-
Aprotinin reduces vasoactive medication use during adult liver transplantation
-
Findlay JY, Kufner RP. Aprotinin reduces vasoactive medication use during adult liver transplantation. J Clin Anesth. 2003;15:19-23.
-
(2003)
J Clin Anesth
, vol.15
, pp. 19-23
-
-
Findlay, J.Y.1
Kufner, R.P.2
-
66
-
-
0035084507
-
Improved early graft survival in patients receiving aprotinin during orthotopic liver transplantation
-
Molenaar IQ, Veldman M, Begliomini B, et al. Improved early graft survival in patients receiving aprotinin during orthotopic liver transplantation. Transplant Proc. 2001;33:1345-1346.
-
(2001)
Transplant Proc
, vol.33
, pp. 1345-1346
-
-
Molenaar, I.Q.1
Veldman, M.2
Begliomini, B.3
-
67
-
-
0029020440
-
Activation of the plasma contact system and hemodynamic changes after graft revascularization in liver transplantation
-
Scholz T, Backman L, Mathisen O, et al. Activation of the plasma contact system and hemodynamic changes after graft revascularization in liver transplantation. Transplantation. 1995;60:36-40.
-
(1995)
Transplantation
, vol.60
, pp. 36-40
-
-
Scholz, T.1
Backman, L.2
Mathisen, O.3
-
68
-
-
0031960064
-
Aprotinin versus lysine analogues: The debate continues
-
Royston D. Aprotinin versus lysine analogues: the debate continues. Ann Thorac Surg. 1998;65:S9-S19.
-
(1998)
Ann Thorac Surg
, vol.65
-
-
Royston, D.1
-
69
-
-
0031030981
-
Prevalence of anaphylactic reactions to aprotinin: Analysis of two hunderd forty-eight reexposures to aprotinin in heart operations
-
Dietrich W, Spath P, Ebell A, et al. Prevalence of anaphylactic reactions to aprotinin: analysis of two hunderd forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg. 1997;113:194-201.
-
(1997)
J Thorac Cardiovasc Surg
, vol.113
, pp. 194-201
-
-
Dietrich, W.1
Spath, P.2
Ebell, A.3
-
70
-
-
0036019819
-
Epsilon-aminocaproic acid and renal complications: Case report and review of the literature
-
Manjunath G, Fozailoff A, Mitcheson D, et al. Epsilon-aminocaproic acid and renal complications: case report and review of the literature. Clin Nephrol. 2002;58:63-67.
-
(2002)
Clin Nephrol
, vol.58
, pp. 63-67
-
-
Manjunath, G.1
Fozailoff, A.2
Mitcheson, D.3
-
71
-
-
0007409964
-
Reduced blood loss at the expense of renal function: Is epsilon-aminocaproic acid a blow to the kidney?
-
Garwood S, Mathew J, Barash P, et al. Reduced blood loss at the expense of renal function: is epsilon-aminocaproic acid a blow to the kidney? Anesthesiology. 1997;87:A67.
-
(1997)
Anesthesiology
, vol.87
-
-
Garwood, S.1
Mathew, J.2
Barash, P.3
-
72
-
-
0020986217
-
High-dosage aprotinin (Trasylol) therapy - Is it safe fore the kidney?
-
Fischer JH, Knupfer P. High-dosage aprotinin (Trasylol) therapy - is it safe fore the kidney? Langenbecks Arch Chir. 1983;360:241-249.
-
(1983)
Langenbecks Arch Chir
, vol.360
, pp. 241-249
-
-
Fischer, J.H.1
Knupfer, P.2
-
73
-
-
0027419287
-
Observations on the early renal uptake and later tubular metabolism of radiolabelled aprotinin (Trasylol) in man: Theoretical and practical considerations
-
Rustom R, Grime JS, Maltby P, et al. Observations on the early renal uptake and later tubular metabolism of radiolabelled aprotinin (Trasylol) in man: theoretical and practical considerations. Clin Sci (Colch). 1993;84:231-235.
-
(1993)
Clin Sci (Colch)
, vol.84
, pp. 231-235
-
-
Rustom, R.1
Grime, J.S.2
Maltby, P.3
-
74
-
-
0028891130
-
Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function
-
Lemmer JH Jr, Stanford W, Bonney SL, et al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function. Ann Thorac Surg. 1995;59:132-136.
-
(1995)
Ann Thorac Surg
, vol.59
, pp. 132-136
-
-
Lemmer Jr., J.H.1
Stanford, W.2
Bonney, S.L.3
-
75
-
-
0029729898
-
Aprotinin: Safe and effective only with the full-dose regimen
-
[editorial]
-
Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen [editorial]. Ann Thorac Surg. 1996;62:1575-1577.
-
(1996)
Ann Thorac Surg
, vol.62
, pp. 1575-1577
-
-
Smith, P.K.1
Muhlbaier, L.H.2
-
76
-
-
31344467254
-
The risk associated with aprotinin in cardiac surgery
-
for the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation
-
Mangano DT, Tudor IC, Dietzel C, for the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353-365.
-
(2006)
N Engl J Med
, vol.354
, pp. 353-365
-
-
Mangano, D.T.1
Tudor, I.C.2
Dietzel, C.3
-
77
-
-
0035956716
-
The effect of aprotinin on renal function in orthotopic liver transplantation
-
Molenaar IQ, Begliomini B, Grazi GL, et al. The effect of aprotinin on renal function in orthotopic liver transplantation. Transplantation. 2001;71:247-252.
-
(2001)
Transplantation
, vol.71
, pp. 247-252
-
-
Molenaar, I.Q.1
Begliomini, B.2
Grazi, G.L.3
-
78
-
-
1242352110
-
Antifibrinolytics in liver transplantation: They are effective, but what about the risk-benefit ratio?
-
Porte RJ. Antifibrinolytics in liver transplantation: they are effective, but what about the risk-benefit ratio? Liver Transplant. 2004;10:285-288.
-
(2004)
Liver Transplant
, vol.10
, pp. 285-288
-
-
Porte, R.J.1
-
79
-
-
1242329511
-
Intravascular thrombosis and thromboembolism during liver transplantation: Antifibrinolytic therapy implicated?
-
Ramsay MA, Randall HB, Burton EC. Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated? Liver Transplant. 2003;10:310-314.
-
(2003)
Liver Transplant
, vol.10
, pp. 310-314
-
-
Ramsay, M.A.1
Randall, H.B.2
Burton, E.C.3
-
80
-
-
0034841692
-
Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation
-
Gologorsky E, De Wolf AM, Scott V, et al. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transplant. 2001;7:783-789.
-
(2001)
Liver Transplant
, vol.7
, pp. 783-789
-
-
Gologorsky, E.1
De Wolf, A.M.2
Scott, V.3
-
81
-
-
34347222630
-
Aprotinin and thromboembolism in liver transplantation: Is there really a causal effect?
-
Molenaar IQ, Porte RJ. Aprotinin and thromboembolism in liver transplantation: is there really a causal effect? Anesth Analg. 2002;94:1367-1368.
-
(2002)
Anesth Analg
, vol.94
, pp. 1367-1368
-
-
Molenaar, I.Q.1
Porte, R.J.2
-
82
-
-
0026584667
-
Different aprotinin applications influencing hemostatic changes in orthotopic liver transplantation
-
Himmelreich G, Muser M, Neuhaus P, et al. Different aprotinin applications influencing hemostatic changes in orthotopic liver transplantation. Transplantation. 1992;53:132-136.
-
(1992)
Transplantation
, vol.53
, pp. 132-136
-
-
Himmelreich, G.1
Muser, M.2
Neuhaus, P.3
-
83
-
-
0028919165
-
Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation
-
Soilleux H, Gillon MC, Mirand A, et al. Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation. Anesth Analg. 1995;80:349-352.
-
(1995)
Anesth Analg
, vol.80
, pp. 349-352
-
-
Soilleux, H.1
Gillon, M.C.2
Mirand, A.3
-
84
-
-
0027434794
-
Tranexamic acid reduces blood loss during orthotopic liver transplantation
-
Yassen K, Bellamy MC, Sadek SA, et al. Tranexamic acid reduces blood loss during orthotopic liver transplantation. Clin Transplant. 1993;7:453-458.
-
(1993)
Clin Transplant
, vol.7
, pp. 453-458
-
-
Yassen, K.1
Bellamy, M.C.2
Sadek, S.A.3
-
85
-
-
33750367068
-
Efficacy and safety of aprotinin in liver transplantation: A meta-analysis of controlled clinical trials
-
[abstract]
-
Molenaar IQ, Groen H, Slooff MJH, et al. Efficacy and safety of aprotinin in liver transplantation: a meta-analysis of controlled clinical trials [abstract]. Liver Transplant. 2005;11:C-1.
-
(2005)
Liver Transplant
, vol.11
-
-
Molenaar, I.Q.1
Groen, H.2
Slooff, M.J.H.3
-
86
-
-
0034767540
-
Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not for a prothrombotic, effect
-
Molenaar IQ, Legnani C, Groenland THN, et al. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not for a prothrombotic, effect. Liver Transplant. 2001;7:896-903.
-
(2001)
Liver Transplant
, vol.7
, pp. 896-903
-
-
Molenaar, I.Q.1
Legnani, C.2
Groenland, T.H.N.3
-
87
-
-
0035221236
-
Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery
-
Landis RC, Asimakopoulos G, Poullis M, et al. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery. Heart Surg Forum. 2001;4(Suppl 1):S35-S39.
-
(2001)
Heart Surg Forum
, vol.4
, Issue.SUPPL. 1
-
-
Landis, R.C.1
Asimakopoulos, G.2
Poullis, M.3
-
88
-
-
0031041434
-
Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography
-
Ben-Ari Z, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol. 1997;26:554-559.
-
(1997)
J Hepatol
, vol.26
, pp. 554-559
-
-
Ben-Ari, Z.1
Panagou, M.2
Patch, D.3
-
89
-
-
17744377992
-
A review of aprotinin in orthotopic liver transplantation: Can its harmful effects offset its beneficial effects?
-
Lentschener C, Roche K, Ozier Y. A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects? Anesth Analg. 2005;100:1248-1255.
-
(2005)
Anesth Analg
, vol.100
, pp. 1248-1255
-
-
Lentschener, C.1
Roche, K.2
Ozier, Y.3
-
90
-
-
0041828549
-
Institutional variability in transfusion practice for liver transplantation
-
Ozier Y, Pessione F, Samain E, et al. Institutional variability in transfusion practice for liver transplantation. Anesth Analg. 2003;97:671-679.
-
(2003)
Anesth Analg
, vol.97
, pp. 671-679
-
-
Ozier, Y.1
Pessione, F.2
Samain, E.3
-
91
-
-
0030694353
-
A surgeon's perspective on the management of coagulation disorders before liver transplantation
-
Bechstein WO, Neuhaus P. A surgeon's perspective on the management of coagulation disorders before liver transplantation. Liver Transplant Surg. 1997;3:653-655.
-
(1997)
Liver Transplant Surg
, vol.3
, pp. 653-655
-
-
Bechstein, W.O.1
Neuhaus, P.2
-
92
-
-
0031045902
-
Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function
-
Miki C, Iriyama K, Gunson BK, et al. Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg. 1997;132:136-141.
-
(1997)
Arch Surg
, vol.132
, pp. 136-141
-
-
Miki, C.1
Iriyama, K.2
Gunson, B.K.3
-
93
-
-
0034722726
-
Prognostic factors for longterm actual patient survival after orthotopic liver transplantation in children
-
Sieders E, Peeters PMJG, TenVergert EM, et al. Prognostic factors for longterm actual patient survival after orthotopic liver transplantation in children. Transplantation. 2000;70:1448-1453.
-
(2000)
Transplantation
, vol.70
, pp. 1448-1453
-
-
Sieders, E.1
Peeters, P.M.J.G.2
TenVergert, E.M.3
-
94
-
-
0035570399
-
Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict
-
Steib A, Freys G, Lehmann C, et al. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth. 2001;48:1075-1079.
-
(2001)
Can J Anaesth
, vol.48
, pp. 1075-1079
-
-
Steib, A.1
Freys, G.2
Lehmann, C.3
-
95
-
-
0034209537
-
Poor prediction of blood transfusion requirements in adult liver transplantation from preoperative variables
-
Findlay JY, Rettke SR. Poor prediction of blood transfusion requirements in adult liver transplantation from preoperative variables. J Clin Anesth. 2000;12:319-323.
-
(2000)
J Clin Anesth
, vol.12
, pp. 319-323
-
-
Findlay, J.Y.1
Rettke, S.R.2
|